Carbamazepine Patent Expiration

Carbamazepine is Used for treating neurological and other disorders such as epilepsy with twice daily oral dosing. It was first introduced by Novartis Pharmaceuticals Corp in its drug Tegretol on Approved Prior to Jan 1, 1982. Other drugs containing Carbamazepine are Equetro, Tegretol-Xr, Carbatrol, Carnexiv. 38 different companies have introduced drugs containing Carbamazepine.


Carbamazepine Patents

Given below is the list of patents protecting Carbamazepine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Carnexiv US11529357 Injectable carbamazepine composition essentially free of 10-bromo-carbamazepine Jan 31, 2040 Lundbeck Pharms Llc
Carnexiv US9493582 Alkylated cyclodextrin compositions and processes for preparing and using the same Feb 27, 2033 Lundbeck Pharms Llc
Carnexiv US7635773 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lundbeck Pharms Llc
Carnexiv US8410077 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lundbeck Pharms Llc
Carnexiv US9750822 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lundbeck Pharms Llc
Carnexiv US9629797 Parenteral carbamazepine formulation Nov 10, 2028 Lundbeck Pharms Llc
Carnexiv US9770407 Parenteral carbamazepine formulation Nov 10, 2028 Lundbeck Pharms Llc
Equetro US6977253 Methods for the treatment of bipolar disorder using carbamazepine May 19, 2024

(Expired)

Validus Pharms
Carbatrol US5912013 Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine Jun 15, 2016

(Expired)

Takeda Pharms Usa
Equetro US5912013 Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine Jun 15, 2016

(Expired)

Validus Pharms



Carbamazepine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Carbamazepine Generic API Manufacturers

Several generic applications have been filed for Carbamazepine. The first generic version for Carbamazepine was by Usl Pharma Inc and was approved on May 15, 1986. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Jul 25, 2025.

Given below is the list of companies who have filed for Carbamazepine generic, along with the locations of their manufacturing plants worldwide.


Carbamazepine News

Potential Treatment: Epilepsy medication shows promise in reducing joint damage and relieving pain caused by osteoarthritis.

18 Jan, 2024

See More